# Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine

> **NCT02684045** · — · COMPLETED · sponsor: **Medtronic Spinal and Biologics** · enrollment: 76 (actual)

## Conditions studied

- Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02684045
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2017-08-15
- **Final completion:** 2017-08-15
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02684045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02684045, "Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02684045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*